Safeguard Scientifics logo

Safeguard Scientifics(OTC) SFE

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1968)-62%
5 Year-60%
1 Year+153%
1 Month+32%
N/A
Safeguard Scientifics last closing stock price
MetricPriceDate
Last closeUSD 0.502026-10-12
Safeguard Scientifics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.73%USD 0.512026-10-05
1 month+31.89%USD 0.382026-09-11
3 month+26.85%USD 0.402026-07-14
Year to date+180.19%USD 0.182025-12-31
1 year+153.42%USD 0.202025-10-10
3 year+209.15%USD 0.162023-10-13
5 year-60.15%USD 1.262021-10-13
Since inception-61.53%USD 1.301968-06-17

Safeguard Scientifics Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.49M

Net Income (TTM)

-$12.13M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Mar 7, 2024

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Safeguard Scientifics

Safeguard Scientifics, Inc. is a financial services company that historically focused on private equity and venture capital investments. The firm has transitioned from actively seeking new investments to managing its existing portfolio, primarily in technology, financial services, and healthcare sectors.

Products and Services
  • Investment management in technology and healthcare sectors
  • Support for early and growth-stage companies
  • Capital for company expansion and management buyouts
Growth Outlook
  • Focus on technology and healthcare sectors presents significant growth opportunities
  • Strong cash position with $4.84 million in cash and cash equivalents
  • Potential for strategic partnerships to enhance portfolio value
Financial Highlights
  • Trailing twelve months (TTM) revenue of $0, indicating a shift in focus
  • Quarterly net income of -$255,000 in Q2 2026, reflecting ongoing management costs
  • Dividend yield of 2.8%, providing a return to shareholders despite operational challenges
Safeguard Scientifics, Inc. has a long-standing history in the investment landscape, having been founded in 1953. The company has shifted its focus from active investment to managing its existing portfolio, which includes a diverse range of companies in technology and healthcare. The firm has historically participated in various funding rounds, providing capital for growth and expansion. The growth outlook for Safeguard Scientifics remains promising, particularly in the technology and healthcare sectors, which are expected to continue evolving and expanding. The company's strong cash position allows for flexibility in pursuing strategic partnerships and enhancing the value of its existing investments. Financially, the company has reported a revenue of $0 in the trailing twelve months, reflecting its transition away from new investments. The recent quarterly results show a net income of -$255,000, primarily due to management expenses. However, the company maintains a dividend yield of 2.8%, which can be attractive to potential investors looking for income generation. Overall, Safeguard Scientifics, Inc. presents a unique opportunity for investors interested in a company with a rich history and a strategic focus on managing its existing portfolio in high-growth sectors.
AI Generated • Oct 5, 2026

Industry

Capital Markets

CEO

Mark Dow

Headquarters

Radnor, PA 19087, US

SFE Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

130.85%

Return on Capital

-46.30%

Return on Assets

284.43%

Earnings Yield

N/A

Dividend Yield

280.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.49M

Operating Income

-$5.68M

EBITDA

-$3.12M

Operating Cash Flow

-$3.31M

Capital Expenditure

$0.00

Free Cash Flow

-$3.31M

Cash & ST Invst.

$9.50M

Total Debt

$1.25M

Safeguard Scientifics Performance Analysis

Safeguard Scientifics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 0N/A
Safeguard Scientifics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-3199.7%
Q22023-06-30-1744.4%
Q32023-09-301100.6%
Q42023-12-31-100.0%
Safeguard Scientifics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.87N/A
20232023-12-31USD -0.61-30.6%
20242024-12-31USD -0.623.1%
20252025-12-31USD 0.10N/A
Safeguard Scientifics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12023-03-3133.3%
Q22023-06-3050.0%
Q32023-09-30133.3%
Q42023-12-31-550.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2023YOY CHG

Revenue

$0.00

+100.0%

Gross Profit

$0.00

+100.0%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

33

N/A

Net Income

-$4.41M

+49.3%

EBITDA

$0.00

+100.0%

Quarterly Fundamentals

Name
Q4 2023YOY CHG

Total Cash

$9.50M

-52.9%

Total Debt

$1.25M

-25.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$760.00K

-39.2%

Short Term Debt

$489.00K

+14.0%

Return on Assets

2.84%

N/A

Return on Invested Capital

-30.08%

N/A

Free Cash Flow

-$818.00K

-36.8%

Operating Cash Flow

-$818.00K

-36.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ATIFATIF Holdings Ltd.
$0.64-12.79%
OSRHOSR Holdings, Inc.
$0.12+0.00%
RFACRF Acquisition Corp.
$2.70-68.60%
JVSAJV SPAC Acquisition Corp. Class A Ordinary Share
$3.64-65.98%

Trending Stocks

Symbol / CompanyPricePrice Chg
CIFRCipher Digital
$11.34-12.77%
BMBLBumble
$5.95+56.58%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$37.42+0.62%
INTCIntel
$102.81+1.44%

Questions About SFE

What is the current price of Safeguard Scientifics?

Safeguard Scientifics is trading at N/A per share.

What is the 52-week range for Safeguard Scientifics?

Over the past 52 weeks, Safeguard Scientifics has traded between N/A and N/A.

How much debt does Safeguard Scientifics have?

As of the most recent reporting period, Safeguard Scientifics reported total debt of $0.00.

How much cash does Safeguard Scientifics have on hand?

Safeguard Scientifics reported $4.84M in cash and cash equivalents in its most recent financial results.

What is Safeguard Scientifics’s dividend yield?

Safeguard Scientifics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.